These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 27785449)

  • 1. Hepatocellular carcinoma: a review.
    Balogh J; Victor D; Asham EH; Burroughs SG; Boktour M; Saharia A; Li X; Ghobrial RM; Monsour HP
    J Hepatocell Carcinoma; 2016; 3():41-53. PubMed ID: 27785449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of hepatocellular carcinoma.
    Crissien AM; Frenette C
    Gastroenterol Hepatol (N Y); 2014 Mar; 10(3):153-61. PubMed ID: 24829542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.
    Asemota J; Saleh M; Igbinovia O; Burns D
    Cureus; 2020 Jul; 12(7):e9191. PubMed ID: 32818122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
    Teixeira AC; Mente ED; Castro-e-Silva O; Sankarankutty AK; Cantão CA; Souza FF; Abud D; Muglia V; Elias-Junior J; Martinelli AL
    Transplant Proc; 2010 Mar; 42(2):502-4. PubMed ID: 20304177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
    Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
    Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and hepatocellular carcinoma.
    Yao F; Terrault N
    Curr Treat Options Oncol; 2001 Dec; 2(6):473-83. PubMed ID: 12057093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma.
    Wang CH; Wey KC; Mo LR; Chang KK; Lin RC; Kuo JJ
    Asian Pac J Cancer Prev; 2015; 16(9):3595-604. PubMed ID: 25987009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Singal AG; Lim JK; Kanwal F
    Gastroenterology; 2019 Jun; 156(8):2149-2157. PubMed ID: 30878469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.
    Ghavimi S; Apfel T; Azimi H; Persaud A; Pyrsopoulos NT
    J Clin Transl Hepatol; 2020 Jun; 8(2):168-176. PubMed ID: 32832397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection for hepatocellular carcinoma.
    Ramesh H
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S90-6. PubMed ID: 25755617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic approach to hepatocellular carcinoma].
    Schacherer D; Schoelmerich J; Zuber-Jerger I
    Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.
    Tohra S; Duseja A; Taneja S; Kalra N; Gorsi U; Behera A; Kaman L; Dahiya D; Sahu S; Sharma B; Singh V; Dhiman RK; Chawla Y
    J Clin Exp Hepatol; 2021; 11(6):682-690. PubMed ID: 34866847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
    Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A
    Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of liver transplantation as treatment modality in patients with hepatocellular carcinoma in cirrhosis: a single-center experience.
    Müller V; Förtsch T; Gündel M; Croner RS; Langheinrich M; Yedibela S; Lohmüller C; Küffner M; Hohenberger W; Perrakis A
    Transplant Proc; 2013 Jun; 45(5):1957-60. PubMed ID: 23769082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of therapy for hepatocellular carcinoma.
    Corey KE; Pratt DS
    Therap Adv Gastroenterol; 2009 Jan; 2(1):45-57. PubMed ID: 21180533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant therapy for hepatocellular carcinoma: is there an optimal approach?
    Almhanna K; Kalmadi S; Pelley R; Kim R
    Oncology (Williston Park); 2007 Aug; 21(9):1116-22; discussion 1122, 1124, 1127-8. PubMed ID: 17910314
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.